119 related articles for article (PubMed ID: 2444731)
1. The structure of bovine retinal S-antigen: sequence analysis and identification of monoclonal antibody epitopes and uveitogenic site.
Shinohara T; Donoso L; Wistow G; Dietzschold B; Craft C; Tao R
Jpn J Ophthalmol; 1987; 31(2):197-206. PubMed ID: 2444731
[TBL] [Abstract][Full Text] [Related]
2. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
Gregerson DS; Obritsch WF; Donoso LA
J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a new, potent, immunopathogenic epitope in S-antigen that elicits T cells expressing V beta 8 and V alpha 2-like genes.
Merryman CF; Donoso LA; Zhang XM; Heber-Katz E; Gregerson DS
J Immunol; 1991 Jan; 146(1):75-80. PubMed ID: 1701801
[TBL] [Abstract][Full Text] [Related]
4. Oligopeptides of three to five residues derived from uveitopathogenic sites of retinal S-antigen induce experimental autoimmune uveitis (EAU) in Lewis rats.
Sunil S; Eto K; Singh VK; Shinohara T
Cell Immunol; 1993 Apr; 148(1):198-207. PubMed ID: 8495487
[TBL] [Abstract][Full Text] [Related]
5. Antigenicity and uveitogenicity of partially purified peptides of a retinal autoantigen, S-antigen.
Banga JP; Kasp E; Ellis BA; Brown E; Suleyman S; Dumonde DC
Immunology; 1987 Jul; 61(3):357-62. PubMed ID: 3497091
[TBL] [Abstract][Full Text] [Related]
6. Identification of a uveitogenic cyanogen bromide peptide of bovine retinal S-antigen and preparation of a uveitogenic, peptide-specific T cell line.
Gregerson DS; Obritsch WF; Fling SP
Eur J Immunol; 1987 Mar; 17(3):405-11. PubMed ID: 3494613
[TBL] [Abstract][Full Text] [Related]
7. Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats.
Singh VK; Kalra HK; Yamaki K; Abe T; Donoso LA; Shinohara T
J Immunol; 1990 Feb; 144(4):1282-7. PubMed ID: 1689349
[TBL] [Abstract][Full Text] [Related]
8. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
9. Immunization with recombinant Escherichia coli expressing retinal S-antigen-induced experimental autoimmune uveitis (EAU) in Lewis rats.
Eto K; Suzuki S; Singh VK; Shinohara T
Cell Immunol; 1993 Mar; 147(1):203-14. PubMed ID: 8462112
[TBL] [Abstract][Full Text] [Related]
10. Analysis of uveitogenic sites in phosducin molecule.
Satoh N; Abe T; Nakajima A; Ohkoshi M; Koizumi T; Tamada H; Sakuragi S
Curr Eye Res; 1998 Jul; 17(7):677-86. PubMed ID: 9678412
[TBL] [Abstract][Full Text] [Related]
11. In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen.
Fling SP; Donoso LA; Gregerson DS
J Immunol; 1991 Jul; 147(2):483-9. PubMed ID: 1712808
[TBL] [Abstract][Full Text] [Related]
12. Peripheral expression of rod photoreceptor arrestin induces an epitope-specific, protective response against experimental autoimmune uveoretinitis.
McPherson SW; Roberts JP; Gregerson DS
Curr Eye Res; 2005 Jun; 30(6):491-502. PubMed ID: 16020282
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte responses to peptide M and to retinal S-antigen in uveitis patients.
Hirose S; Donoso LA; Shinohara T; Palestine AG; Nussenblatt RB; Gery I
Jpn J Ophthalmol; 1990; 34(3):298-305. PubMed ID: 1706787
[TBL] [Abstract][Full Text] [Related]
14. Rodent models of experimental autoimmune uveitis.
Agarwal RK; Caspi RR
Methods Mol Med; 2004; 102():395-419. PubMed ID: 15286397
[TBL] [Abstract][Full Text] [Related]
15. Immunologic and biochemical properties of several retinal proteins bound by antibodies in sera from animals with experimental autoimmune uveitis and uveitis patients.
Gregerson DS; Abrahams IW
J Immunol; 1983 Jul; 131(1):259-64. PubMed ID: 6863917
[TBL] [Abstract][Full Text] [Related]
16. [Experimental autoimmune uveitis and retinitis induced by S-antigen immunization].
Misiuk-Hojło M; Ruiz-Moreno J; Thillaye B; de Kozak Y
Klin Oczna; 1993; 95(3-4):101-4. PubMed ID: 8377430
[TBL] [Abstract][Full Text] [Related]
17. Human S-antigen: presence of multiple immunogenic and immunopathogenic sites in the Lewis rat.
de Smet MD; Bitar G; Roberge FG; Gery I; Nussenblatt RB
J Autoimmun; 1993 Oct; 6(5):587-99. PubMed ID: 7694588
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a potent uveitopathogenic site derived from rat phosducin.
Abe T; Satoh N; Nakajima A; Koizumi T; Tamada M; Sakuragi S
Exp Eye Res; 1997 Nov; 65(5):703-10. PubMed ID: 9367650
[TBL] [Abstract][Full Text] [Related]
19. Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis.
Donoso LA; Merryman CF; Sery T; Sanders R; Vrabec T; Fong SL
J Immunol; 1989 Jul; 143(1):79-83. PubMed ID: 2786534
[TBL] [Abstract][Full Text] [Related]
20. Preparation of a uveitogenic peptide by chymotryptic digestion of bovine S-antigen.
Kamada Y; Yamada M; Das ND; Samuelson D; Leverenz VR; Shichi H
Invest Ophthalmol Vis Sci; 1985 Sep; 26(9):1274-80. PubMed ID: 4030254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
